Opportunities and awards
Writing and poetry prize entries now open, 2024 festival performer callouts, plus finalists of Incinerator Art Award, and more!
Stay updated with breaking news from David Fleischer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Writing and poetry prize entries now open, 2024 festival performer callouts, plus finalists of Incinerator Art Award, and more!
In his interview, Fleischer discussed the beginning of a new phase 3 trial for a peanut immunotherapy patch known as DBV712.
Montrouge, France, March 7, 2023 DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 - 7 Years Old First patient screened at Midwest
Montrouge, France, February 21, 2023 DBV Technologies to Participate in Upcoming AAAAI 2023 Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage
Republicans are seeking fresh elections in nearly two dozen contests, alleging Election Day woes cost them thousands of votes, but a surge in Democratic registration and long-term demographic trends provide simpler explanations for GOP losses.